title: PTEN sumo-wrestles human RAD52 to mystery land.
authors.affiliation: Rutgers Cancer Institute of New Jersey; Department of Radiation Oncology; Rutgers Robert Wood Johnson Medical School; Rutgers, The State University of New Jersey; New Brunswick, NJ USA.
authors.forename: Zhiyuan
authors.initials: Z
authors.lastname: Shen
authors.forename: Steven
authors.initials: S
authors.lastname: Huhn
mesh_terms: D047390:Casein Kinase II / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism*; D002843:Chromatin / Q000378:metabolism*; D004260:DNA Repair; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism*; D006801:Humans; D051059:PTEN Phosphohydrolase / Q000378:metabolism*; D051721:Rad52 DNA Repair and Recombination Protein / Q000378:metabolism*
chemical_list: D002843:Chromatin; D051721:Rad52 DNA Repair and Recombination Protein; D047390:Casein Kinase II; D038362:Glycogen Synthase Kinase 3; D051059:PTEN Phosphohydrolase
keywords: BRCA2; PARP inhibitor; PTEN; Poly-ADP ribose polymerase; RAD51; RAD52; homologous recombination; sumoylation; synthetic lethality